WCM Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

WCM Investment Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,900	Closed	-$238K	–	101
2015 Q3	$238K	Hold	5,900	–	–	0.01%	104
2015 Q2	$340K	Hold	5,900	–	–	0.01%	109
2015 Q1	$376K	Hold	5,900	–	–	0.01%	130
2014 Q4	$364K	Hold	5,900	–	–	0.01%	109
2014 Q3	$229K	Hold	5,900	–	–	0.01%	112
2014 Q2	$203K	Hold	5,900	–	–	0.01%	140
2014 Q1	$255K	Hold	5,900	–	–	0.01%	136
2013 Q4	$235K	Hold	5,900	–	–	0.01%	128
2013 Q3	$221K	Buy	+5,900	New	+$176K	0.01%	125

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

WCM Investment Management's IONS Position: Q4 2015 in Review

WCM Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2015, closing a stake of 5,900 shares — an estimated $238K sold.

WCM Investment Management first reported a position in IONS in Q3 2013 and held it in 9 quarters. The position peaked at $376K in Q1 2015. 334 funds tracked by Wall St. Rank hold IONS as of Q4 2015.

WCM Investment Management reported no remaining Ionis Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
WCM Investment Management sold 5,900 Ionis Pharmaceuticals shares in Q4 2015, an estimated $238K.
WCM Investment Management first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 9 quarters.
WCM Investment Management's Ionis Pharmaceuticals position peaked at $376K in Q1 2015.
334 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2015.

Based on WCM Investment Management's 13F filing for Q4 2015, filed 10 Feb 2016.